05/23/2024
4:05 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:03 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:04 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:10 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Necina Roman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/17/2024
3:15 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:15 PM | Hookipa Pharma (Issuer)
Orlinger Klaus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
3:19 PM | Hookipa Pharma (Issuer)
Winderlich Mark (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/22/2024
6:33 AM | Hookipa Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
6:08 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
4:47 PM | Hookipa Pharma (Subject)
| Form SC 13G/A | |
02/14/2024
4:47 PM | EcoR1 Capital, LLC (Filed by)
EcoR1 Capital, LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
01/31/2024
3:30 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
7:12 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
11:15 PM | Hookipa Pharma (Filer)
| Form EFFECT | |
12/22/2023
3:07 PM | GILEAD SCIENCES, INC. (Reporting)
Hookipa Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/22/2023
6:33 AM | Hookipa Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
12/21/2023
6:06 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:46 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:05 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:10 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023
3:05 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
7:47 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
7:01 AM | Hookipa Pharma (Subject)
| Form SC TO-I/A | |
09/11/2023
7:23 AM | FMR LLC (Filed by)
Hookipa Pharma (Subject)
| Form SC 13G/A | |
08/10/2023
6:05 AM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
6:07 AM | Hookipa Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023
5:21 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
4:06 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
6:37 PM | Aldag Jorn (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:06 PM | Hookipa Pharma (Issuer)
Kandera Reinhard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
10:04 AM | Hookipa Pharma (Subject)
Knoll Capital Management, LLC (Filed by)
| Form SC 13G | |
06/09/2023
4:13 PM | Coelho Mary Theresa (Reporting)
Hookipa Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:13 PM | Hookipa Pharma (Issuer)
Kaufman David Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:14 PM | Hookipa Pharma (Issuer)
van de Winkel Jan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:15 PM | Hookipa Pharma (Issuer)
O'Neill Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:16 PM | Hookipa Pharma (Issuer)
Reilly Timothy P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:16 PM | Hookipa Pharma (Issuer)
Peters Malte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:17 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
05/31/2023
4:24 PM | Hookipa Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
